Bioengineered Protein Drugs Market

Introduction

The application of engineering methods and technology to the field of biology is called as bioengineering. Proteins are polymer of amino acids and play an important role in the function of body. Bioengineered proteins are synthesized using genetic engineering.

They are also called as recombinant protein. Bioengineered protein drugs are used in treatment of human injury, treatment of cancers, hormonal disorders and chronic diseases such as diabetes, asthma, heart disease etc.

Bioengineered protein drugs are target specific and are highly efficient, they are said to have better PK and PD. The bioengineered protein drugs match the natural biological process and therefore they have lower side effects and higher acceptance as compared to small molecule drug.

These are few of the key factors attributing the growth of the global bioengineered protein drug market. In addition to these, the time duration required for the FDA approval and clinical development process is comparatively less than small molecule drugs which is a significant factor driving the growth of the global bioengineered protein drug market.

Huge development in biopharmaceuticals, technological advancement in drug delivery system are driving the growth of the global market. Furthermore, rise in prevalence of chronic disease such as diabetes, asthma and systemic diseases like cancer is likely to propel the growth of the global bioengineered protein drugs market.

According to WHO, the worldwide diabetes population will grow to 366 million by 2030, influencing positively the rapid growth in global bioengineered protein drug market through 2024. However, the complication involved in treatment of disease using bioengineered protein drugs and the ever increasing cost of the drugs is likely to hamper the growth of global market during the forecast period.

The global bioengineered protein drugs market is segmented on the basis of product types, application types, technology types, drug delivery methods and geographical regions.

Market Segmentation

Based on Product Type	Cytokines and Chemokines Peptide Hormones Peptide antibiotics Monoclonal antibodies Therapeutics and enzymes Vaccines Other Bioengineered protein drugs
Based on Application Type	Diabetes and hormonal disorders Genetic and fertility disorders Cancer and Immunosuppressive disorders Other diseases
Based on Technology Type	Fractionation Bioreactors and microbial cell fermentation Genetic Engineering Pharming Cell culture and other
Based on Drug Delivery Methods	Traditional methods Novel Methods

The report covers exhaustive analysis on:

• Bioengineered Protein Drugs Market Segments
• Bioengineered Protein Drugs Market Dynamics
• Historical Actual Market Size, 2013 - 2015
• Bioengineered Protein Drugs Market Size & Forecast 2016 to 2024
• Bioengineered Protein Drugs Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Bioengineered Protein Drugs Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa 

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

To know more about delivery timeline for this report Contact Sales